Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Income from Continuing Operations (2016 - 2025)

OptimizeRx (OPRX) has disclosed Income from Continuing Operations for 16 consecutive years, with 5020000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 6535.9% to 5020000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5132000.0 through Dec 2025, up 125.52% year-over-year, with the annual reading at 5132000.0 for FY2025, 125.52% up from the prior year.
  • Income from Continuing Operations hit 5020000.0 in Q4 2025 for OptimizeRx, up from 779000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 5020000.0 in Q4 2025 to a low of 11740000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 2560068.05 across 5 years, with a median of 2532000.0 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 8790.01% in 2022 and later skyrocketed 6535.9% in 2025.
  • Year by year, Income from Continuing Operations stood at 623462.0 in 2021, then plummeted by 152.26% to 325836.0 in 2022, then crashed by 3503.04% to 11740000.0 in 2023, then soared by 99.34% to 78000.0 in 2024, then surged by 6535.9% to 5020000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for OPRX at 5020000.0 in Q4 2025, 779000.0 in Q3 2025, and 1532000.0 in Q2 2025.